Health CanadaGeneral Alert
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
Published: December 2, 2019Recall ID: 48046Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
Recalling Firm: Marketed health products
Reason for Recall / Hazard
Product safety
Product Description & Identification
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 48046 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/xeljanz-xeljanz-xr-tofacitinib-risk-thrombosis |
| Issue | Product safety |
| Title | XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2019-12-02 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis Check if your household is affected: https://therecallfile.com/recalls/xeljanz-xeljanz-xr-tofacitinib-risk-of-thrombosis/CANADA-48046
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordXELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis